TUBB1 dysfunction in inherited thrombocytopenia causes genome instability.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
06 2019
Historique:
received: 05 09 2018
accepted: 18 12 2018
pubmed: 12 3 2019
medline: 13 6 2020
entrez: 12 3 2019
Statut: ppublish

Résumé

Inherited thrombocytopenia is a genetically heterogeneous disease characterized by varying degrees of thrombocytopenia and risk of haematological malignancy, and the genetic cause of many cases remains unknown. We performed whole-exome sequencing of a family with thrombocytopenia and myeloid malignancy and identified a novel TUBB1 variant, T149P. Screening of other thrombocytopenia pedigrees identified another TUBB1 variant, R251H. TUBB1 encodes the tubulin β-1 chain, a major component of microtubules abundant in megakaryocytes. Variant TUBB1 disrupted the normal assembly of microtubules and impaired proplatelet formation in vitro. In addition, DNA damage response was severely attenuated by loss of TUBB1. We found that the nuclear accumulation of p53 (also termed TP53) and the expression of pro-apoptotic genes triggered by genotoxic stress were blocked in TUBB1-deficient cells and, accordingly, apoptosis after DNA damage was diminished by knockdown of TUBB1. Thus, we have demonstrated that microtubule dysfunction confers resistance to apoptosis, even in DNA damage-accumulated cells, which explains genome instability in the affected individuals. These studies will lead us to a better understanding of how microtubule dysfunction can contribute to the accumulation of DNA damage, genetic instability and leukaemogenesis.

Identifiants

pubmed: 30854628
doi: 10.1111/bjh.15835
doi:

Substances chimiques

TP53 protein, human 0
TUBB1 protein, human 0
Tubulin 0
Tumor Suppressor Protein p53 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

888-902

Informations de copyright

© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Auteurs

Takayoshi Matsumura (T)

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Ayako Nakamura-Ishizu (A)

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
International Research Centre for Medical Sciences, Kumamoto University, Kumamoto, Japan.

Kensuke Takaoka (K)

Department of Haematology and Oncology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.

Hiroaki Maki (H)

Department of Haematology and Oncology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.

Siva S N A Muddineni (SSNA)

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Chelsia Q Wang (CQ)

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Hitoshi Suzushima (H)

Kumamoto Shinto General Hospital, Kumamoto, Japan.

Makoto Kawakita (M)

Kumamoto Dai-Ichi Hospital, Kumamoto, Japan.

Norio Asou (N)

International Medical Centre, Saitama Medical University, Saitama, Japan.

Masao Matsuoka (M)

Department of Haematology, Rheumatology, and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto, Japan.

Mineo Kurokawa (M)

Department of Haematology and Oncology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.

Motomi Osato (M)

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
International Research Centre for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Centre for Metabolic Regulation of Healthy Aging, Kumamoto University, Kumamoto, Japan.

Toshio Suda (T)

Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
International Research Centre for Medical Sciences, Kumamoto University, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH